Life Science & Healthcare
Joseph Bellanti, MD
Professor of Pediatrics & Microbiology-Immunology
Director, Immunology Center
Georgetown University Medical Center
Roger Berlin, MD
Founder and Principal, 1.618 Consulting, LLC
Former CEO and Director, Arno Therapeutics
Former President of Global R&D, Wyeth Consumer Healthcare
Former Head of Global Clinical Research Operations, Merck
Bruce Crosby, MBA
Managing Partner, Health Velocity Capital
Former Senior Vice President, Strategic Market, Program and Professional Development, Hospice Compassus
Former SVP, Corporate Development, Healthways, Inc.
Former Business Development, Pfizer
Former Venture Capital Investor, JPMorgan Partners
Tim Duffy
VP, Business Development, Omeros Corporation
Former Chief Business Officer, MDRNA Inc.
Former VP, Business Development, Prometheus Laboratories
Former Procter & Gamble Pharmaceuticals
Donald Ellis, PharmD, MBA
Managing Director & Senior Analyst, JMP Securities LLC
Former Managing Director, Specialty Pharmaceuticals and Biopharmaceuticals, Avondale Partners
Former Partner/Managing Director at Thomas Weisel Partners (acquired by Stifel Nicholas)
Former Partner/Managing Director at Robertson Stephens & Co.
Former Research Analyst at Montgomery Securities
Former Former clinical pharmacologist with the VA Medical Center and Kaiser Permanente hospital systems
Professor of Pediatrics & Microbiology-Immunology
Director, Immunology Center
Georgetown University Medical Center
Roger Berlin, MD
Founder and Principal, 1.618 Consulting, LLC
Former CEO and Director, Arno Therapeutics
Former President of Global R&D, Wyeth Consumer Healthcare
Former Head of Global Clinical Research Operations, Merck
Bruce Crosby, MBA
Managing Partner, Health Velocity Capital
Former Senior Vice President, Strategic Market, Program and Professional Development, Hospice Compassus
Former SVP, Corporate Development, Healthways, Inc.
Former Business Development, Pfizer
Former Venture Capital Investor, JPMorgan Partners
Tim Duffy
VP, Business Development, Omeros Corporation
Former Chief Business Officer, MDRNA Inc.
Former VP, Business Development, Prometheus Laboratories
Former Procter & Gamble Pharmaceuticals
Donald Ellis, PharmD, MBA
Managing Director & Senior Analyst, JMP Securities LLC
Former Managing Director, Specialty Pharmaceuticals and Biopharmaceuticals, Avondale Partners
Former Partner/Managing Director at Thomas Weisel Partners (acquired by Stifel Nicholas)
Former Partner/Managing Director at Robertson Stephens & Co.
Former Research Analyst at Montgomery Securities
Former Former clinical pharmacologist with the VA Medical Center and Kaiser Permanente hospital systems
Olivier Fontaine, PharmD, MIM
Founding Member & President, OLFON CONSULTING S.A.S
Former General Manager Perrigo BCH French Affiliate, Perrigo Company plc (NYSE: PRGO)
Former Chief Strategy and Innovation Officer, Perrigo Branded Consumer Healthcare, (Omega Pharma)
Former CEO of Darphin and Global General Manager Estée Lauder Professional and Pharmacy Channels, Estée Lauder Companies (NYSE: EL)
Former President & CEO, Pierre Fabre Dermo Cosmetique USA, Inc., Pierre Fabre Group
Former General Manager, Cosmetique Active Division, L’OREAL International Development Manager for La Roche-Posay
Kevin J. Esval
President, VelocityHealth Securities, Inc.
Former Divisional COO of UnitedHealth Group
Kenneth J. Holroyd, MD, MBA
Assistant Vice Chancellor for Research
Medical Director, Center for Technology Transfer and Commercialization
Adjunct Professor of Management
Vanderbilt University
Former COO, Genaera Corporation
Ken Masuo, MBA
Founder, Out-of-the-Box (healthcare consulting services)
Board of Evaluation Committee for Japan Agency for Medical Research and Development (AMED)
Former President of Konica Minolta Precision Medicine Japan KK
Former Senior VP and Japan Representative of Oncology Business, AstraZeneca KK
Former Senior VP, GlaxoSmithKline KK
Former VP, Daiichi Pharmaceutical UK
Leonard L. Mazur
Chairman, Citius Pharmaceuticals Inc
Vice Chairman, Akrimax Pharmaceuticals
Former COO, Triax Pharmaceuticals, Inc.
Joel Peek, PhD
CEO, President and Founder, Alimetrix, Inc.
CEO, Microarrays, Inc.
Founding Member & President, OLFON CONSULTING S.A.S
Former General Manager Perrigo BCH French Affiliate, Perrigo Company plc (NYSE: PRGO)
Former Chief Strategy and Innovation Officer, Perrigo Branded Consumer Healthcare, (Omega Pharma)
Former CEO of Darphin and Global General Manager Estée Lauder Professional and Pharmacy Channels, Estée Lauder Companies (NYSE: EL)
Former President & CEO, Pierre Fabre Dermo Cosmetique USA, Inc., Pierre Fabre Group
Former General Manager, Cosmetique Active Division, L’OREAL International Development Manager for La Roche-Posay
Kevin J. Esval
President, VelocityHealth Securities, Inc.
Former Divisional COO of UnitedHealth Group
Kenneth J. Holroyd, MD, MBA
Assistant Vice Chancellor for Research
Medical Director, Center for Technology Transfer and Commercialization
Adjunct Professor of Management
Vanderbilt University
Former COO, Genaera Corporation
Ken Masuo, MBA
Founder, Out-of-the-Box (healthcare consulting services)
Board of Evaluation Committee for Japan Agency for Medical Research and Development (AMED)
Former President of Konica Minolta Precision Medicine Japan KK
Former Senior VP and Japan Representative of Oncology Business, AstraZeneca KK
Former Senior VP, GlaxoSmithKline KK
Former VP, Daiichi Pharmaceutical UK
Leonard L. Mazur
Chairman, Citius Pharmaceuticals Inc
Vice Chairman, Akrimax Pharmaceuticals
Former COO, Triax Pharmaceuticals, Inc.
Joel Peek, PhD
CEO, President and Founder, Alimetrix, Inc.
CEO, Microarrays, Inc.